Pearl Therapeutics is developing unique dual and triple combination products for the treatment of widely prevalent respiratory diseases, including chronic obstructive pulmonary disease.
Pearl's current focus is on making advanced inhaled therapies available to broad patient populations via familiar and accepted metered dose inhalers.
Pearl is a privately held company led by a seasoned team of respiratory product development experts. Pearl aims to offer patients and healthcare providers alternatives that better meet their needs and improve upon the safety and efficacy of existing respiratory therapeutics to achieve better clinical outcomes.
Past Team (6)Update
Funding Rounds (6) - $232MUpdate
Venture capital Firm
A venture capital firm
Clarus Ventures is a life sciences venture capital firm.
Health-Care Focused VC Firm
Nektar Therapeutics develops therapeutics based on its advanced polymer conjugate chemistry...
200 Saginaw Drive
Redwood City, CA 94063